Back to Search
JOHN KNOX, MD
MD
Pediatrics Physician
NPI: 1750346961Individual
Specialties, Licenses & Credentials
Research & Publications (20)
A phase I-II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798).
PMID 18060598·Invest New Drugs·2008
3-trial
A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168).
PMID 18196204·Invest New Drugs·2008
3-trial
Phase II study of Triapine in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161).
PMID 17393073·Invest New Drugs·2007
3-trial
Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors.
PMID 17064076·J Med Chem·2006
8-other
Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.
PMID 15800324·J Clin Oncol·2005
3-trial
A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix.
PMID 15737556·Eur J Cancer·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1100 LAKE HEARN DR NE, SUITE 100
ATLANTA, GA 30342 - Phone
- (404) 256-3178
Quick Facts
- NPI
- 1750346961
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile